Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
Grigoris Gerotziafas, Professor of Hematology at the Faculty of Medicine, Sorbonne University, Paris, and Head of the Thrombosis Department at Tenon Hospital in Paris, shared an insightful post on LinkedIn:
“We are pleased to share the publication, led by Prof. Alfonso Tafur (Department of Medicine, Vascular Medicine, Endeavor Health, Evanston, Illinois, University of Chicago, USA), of an important article on “Extended anticoagulation in patients with cancer-associated venous thromboembolism.”
This work highlights the challenges and strategies for managing CAT in oncology care and underscores the impact of the API-CAT study on optimizing antithrombotic treatment for patients with cancer-associated thrombosis.
The article emphasizes the urgent need to establish dedicated cancer thrombosis clinics to support shared decision-making and provide tailored management for patients.
We are proud to contribute to this significant initiative in collaboration with:
- CaVITE Thrombosis Center, Centre de Recherche Saint-Antoine (CRSA), INSERM U938, Sorbonne University, Paris, France, and
- Center for Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Chicago, USA.
Together, we aim to bridge science and clinical practice, delivering patient-centered strategies that enhance diagnosis, treatment, and prognosis for individuals facing cancer-associated thrombosis.”
Read the full article here:
Article: Extended anticoagulation in patients with cancer-associated venous thromboembolism
Authors: Atefeh Ghorbanzadeh, Mateo Porres-Aguilar, Robert McBane, Grigoris Gerotziafas, Alfonso Tafur
Discover the latest developments in coagulation and thrombosis research with Hemostasis Today.
-
Aug 26, 2025, 10:02Women’s Equality Day: HFA Recognizes Women with Bleeding Disorders
-
Aug 26, 2025, 09:59Rare Disease Advisor – RBC Rheology Alterations in Hemophilia with Arthropathy
-
Aug 26, 2025, 09:57HFA Supports Future Planning for People with Bleeding Disorders
-
Aug 26, 2025, 09:56Phillip Taboada: TXA Shows No Added Benefit in Aquablation
-
Aug 26, 2025, 09:50A Global Collaboration: PERT Consortium Expands Reach in PE Care
-
Aug 26, 2025, 09:54TSUBASA Study: Emicizumab Improves Daily Life and Motivation in Hemophilia A Patients
-
Aug 26, 2025, 09:38Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
-
Aug 26, 2025, 09:35Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 09:19Parham Dastjerdi – Clonal Hematopoiesis and VTE Risk
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!